Type 2 Diabetes Mellitus (DM): Clinical Trials

9 trials for Type 2 Diabetes Mellitus (DM), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 not yet recruiting, 1 active not recruiting, 1 completed, 1 recruiting. 5 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable5Not yet recruiting 2, Active not recruiting 1, Completed 1, Recruiting 1
Phase 22Not yet recruiting 2

Follow Type 2 Diabetes Mellitus (DM): new trials by email Literature Review of Type 2 Diabetes Mellitus (DM) trials Research Report on Type 2 Diabetes Mellitus (DM)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of VCT220 Tablets in Adults With Type 2 Diabetes and Inadequate Blood Glucose Control
VCT220 tablets, Placebo - Type 2 Diabetes Mellitus (DM)
Phase 2Not yet recruitingVincentage Pharma Co., Ltd1202026-11-012026-10-13
Preoperative Gastric Volume and High-Risk Gastric Content in Patients With Type 2 Diabetes Mellitus
Preoperative Gastric Ultrasonography, Capillary Fasting Blood Glucose Measurement - Type 2 Diabetes Mellitus (DM), Gastric Ultrasound
Not yet recruitingBakirkoy Dr. Sadi Konuk Research and Training Hospital1202026-10-012026-09-30
Preoperative Oral Carbohydrate Loading in Patients With Type 2 Diabetes Undergoing Gastrointestinal Surgery
Standard ERAS Fasting and Clear-Fluid Management, Oral Carbohydrate Loading, Intravenous Glucose - Type 2 Diabetes Mellitus (DM), Gastrointestinal Surgery
Not applicableNot yet recruitingThe Affiliated Hospital of Qingdao University1262026-10-012026-09-21
Effect of Otago vs. Sensorimotor Training on Balance and Fall Risk in People With Diabetes
Otago Exercise Program, Sensorimotor Training - Type 2 Diabetes Mellitus (DM), Accidental Falls
Not applicableNot yet recruitingCairo University402026-10-012026-10-02
Tolerability and Safety of Nano-Tocotrienols
Nano-tocotrienols, Placebo - Type 2 Diabetes Mellitus (DM)
Phase 2Not yet recruitingUniversity of Malaya3602026-10-012026-10-22
Proteome-Wide Association and LLM-Based Prioritization of Type 2 Diabetes Protein Targets
Type 2 Diabetes Mellitus (DM)
Not yet recruitingLouisiana State University Health Sciences Center in New Orleans319942026-09-152026-09-28
Mulligan Mobilization With Movement Versus Conventional Physiotherapy on Ankle Range of Motion, Mobility, Pain, and Quality of Life in Patients With Type 2 Diabetes Mellitus
Experimental, Control - Type 2 Diabetes Mellitus (DM)
Not applicableRecruitingIbadat International University, Islamabad562026-03-022026-09-18
Nature Image Exposure in Type 2 Diabetes
Nature Image Exposure - Type 2 Diabetes Mellitus (DM)
Not applicableCompletedDicle University642023-11-012026-09-21
Community-based, eHealth Supported Type 2 Diabetes Care by Lay Village Health Workers in Rural Lesotho
DM care package, Referral to the responsible health facility - Type 2 Diabetes Mellitus (DM)
Not applicableActive not recruitingUniversity Hospital, Basel, Switzerland2522023-05-132026-09-10

Narrower conditions

Diabetes Mellitus, Type 2 (9)  ·  Pain (2)  ·  Diabetes Mellitus (1)  ·  Noncommunicable Diseases (1)

Broader conditions

Endocrine System Diseases (9)  ·  Glucose Metabolism Disorders (9)  ·  Metabolic Diseases (9)  ·  Nutritional and Metabolic Diseases (9)  ·  Diabetes Mellitus (8)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Neurologic Manifestations (2)  ·  Signs and Symptoms (2)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)

Interventions

Diet, Carbohydrate Loading (1)  ·  Glucose Tolerance Test (1)

Sponsors

Bakirkoy Dr. Sadi Konuk Research and Training Hospital (1)  ·  Cairo University (1)  ·  Dicle University (1)  ·  Ibadat International University, Islamabad (1)  ·  Louisiana State University Health Sciences Center in New Orleans (1)  ·  The Affiliated Hospital of Qingdao University (1)  ·  University Hospital, Basel, Switzerland (1)  ·  University of Malaya (1)  ·  Vincentage Pharma Co., Ltd (1)

Countries

Turkey (Türkiye) (2)  ·  China (1)  ·  Lesotho (1)  ·  Malaysia (1)  ·  Pakistan (1)  ·  Switzerland (1)

Top investigators

Alain Amstutz, MD (1)  ·  Hafsah Arshad, PhD (1)  ·  Lee Ling Lim, FRCP (London) (1)  ·  Niklaus Labhardt, Prof. (1)

Results publications

PMID 37883294, PMID 38654864, PMID 39663603, PMID 42174613

NIH funding

U24DK132740 (1)